Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
FDA Approves Roche's Itovebi for Breast Cancer
Evonik to Restructure Keto and Pharma Amino Acid Business
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Lipocine Enters Exclusive Supply and Distribution Agreement with Pharmalink
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Evonik to Restructure Keto and Pharma Amino Acid Business
Application of QbD Approach for Tech Transfer and Process Characterization of Biologics
Rommelag CDMO
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Nipro Launches D2F Glass Vials Using Stevanato's EZ-fill Technology
Thermo Fisher Scientific to Leverage DHL Express GoGreen Plus Service
SK pharmteco, Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Pharma Matters Q&A: Rising Above the Rest
Avara Highlights Recent Expansions and Core Capabilities
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Application of QbD Approach for Tech Transfer and Process Characterization of Biologics
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Arbele Enters AI Alliances in Precision Oncology and Manufacturing
Panthera Biopartners Joins Parexel Site Alliance Vaccine Network
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Rottendorf Pharma Selects ValGenesis VLMS
FDA sIRB Mandate: A Chance to Reassess Site Performance
Rottendorf Pharma Selects ValGenesis’ VLMS
U.S. House of Representatives Passes the BIOSECURE Act
Post-COVID Trends in Biopharma Contract Manufacturing
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
CMC Pharmaceuticals
Abzena
AMERIPHARMA
UBI Pharma Inc.
Syngene International Ltd.
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
CMC Pharmaceuticals
Abzena
AMERIPHARMA
UBI Pharma Inc.
Syngene International Ltd.
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Drug Delivery
All
Analytical Services
Bioanalytical Services
Bioassay Development
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Breaking News
|
Drug Delivery
|
Industry News
Halozyme, argenx Expand Exclusive ENHANZE Agreement
argenx nominates four new targets for Halozyme's ENHANZE drug delivery technology.
10.04.24
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
Halozyme Therapeutics, argenx Expand Global Collaboration & License Agreement
argenx has nominated 4 additional targets, expanding its exclusive access to Halozyme’s ENHANZE drug delivery technology.
10.03.24
cGMP Manufacture
|
Drug Delivery
|
Drug Development
|
Solid Dosage/Creams/Ointments
The Future of Drug Development in the Gummy Space
Bridging expertise in confectionery and pharmaceuticals to pioneer the next generation of gummy-based OTC and Rx drugs.
Sponsored
released by
Avema Pharma Solutions
10.03.24
Drug Delivery
|
Drug Development
Merge Ahead: Drug-Device Combination Products from Concept to Commercialization
Combining a therapy with its delivery system means navigating two slippery, slowly converging roads en route to a successful launch.
Bill Welch, Executive Director Market Development, PCI Pharma Services
10.01.24
Breaking News
|
cGMP Manufacture
|
Drug Delivery
|
Industry News
Renaissance Supports Launch of First Nasal Spray for Anaphylaxis
Recent campus expansion and investment in two additional packaging lines will support manufacture of forecasted volumes.
09.30.24
Drug Delivery
|
Industry News
Bormioli Pharma, Asamedic Partner for Drug Coxor
Coxor leverages the EasyRec system, a dual-chamber packaging kit that allows for the instant reconstitution of powdered medication into liquid.
09.19.24
Breaking News
|
Drug Delivery
|
Formulation Development
|
Industry News
Lonza Launches Innovaform Accelerator CoE in France
New facility includes technology platforms for capsule and formulation development to support delivery of challenging APIs.
09.19.24
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
|
Drug Development
Ritedose Partners with Verona to Deliver Ohtuvayre
Will deliver significant doses of the new novel product for Chronic Obstructive Pulmonary Disease (COPD).
09.17.24
Breaking News
|
Drug Delivery
|
Industry News
Molex Agrees to Purchase Vectura Group
Will combine the strengths of Vectura and Philips Medisize to deliver a broader portfolio of inhalation combination drug devices and solutions.
09.17.24
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
APL and CurifyLabs Partner for 3D-Printed Medicines
Aim to improve the administration of medicines to children and critically ill patients using novel 3D printing technology.
09.05.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
|
Fill/Finish
LTS, GRAM Enter Strategic Fill Finish Pact for Wearable Injectors
Aims to offer a comprehensive solution for development and manufacturing of wearable injectors for the delivery of biologics.
08.09.24
Aseptic Processing
|
Drug Delivery
|
Fill/Finish
|
Injectables
|
Parenterals
Pharma Matters Q&A: Grand River Aseptic Manufacturing
A Q&A with Mary Lou Glotzbach, senior business development manager at Grand River Aseptic Manufacturing, about injectable drug delivery trends.
Sponsored
released by
Grand River Aseptic Manufacturing
07.29.24
Drug Delivery
|
Drug Development
|
Formulation Development
|
Solid Dosage/Creams/Ointments
Pharma Matters Q&A: AustinPx
Talking next-gen amorphous dispersion technology with Dave Miller, Chief Scientific Officer of AustinPx.
Sponsored
released by
AustinPx
07.29.24
Drug Delivery
|
Facilities
Bespak Reaches Milestone in Capacity Expansion for Greener Inhalers
Further expansion plans underway to meet global customer demand for climate friendly inhalers.
06.12.24
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
SCHOTT Pharma, KORU Medical Systems Partner on Drug Delivery System
Aims to advance large volume subcutaneous infusion.
06.07.24
Breaking News
|
Drug Delivery
|
Industry News
Kindeva Expands Loughborough, UK Facilities
Doubles Kindeva’s UK lab footprint, expands operations, and will relocate approximately 50 quality control employees.
06.04.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
|
Drug Development
RevolKa Signs Master Service Agreement with Daiichi Sankyo
Will create and deliver functional proteins in collaboration with Daiichi Sankyo by using its protein engineering platform technology.
05.28.24
Drug Delivery
The New Bespak: Championing Sustainability with Chris Hirst
He talks to us about key developments in the inhalation industry and how the formation of a leading global CDMO can provide support in navigating these changes.
Sponsored
released by
Bespak
05.07.24
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
|
Drug Development
BioArctic, Eisai Ink Research Agreement for BAN2802 in AD
To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.
04.22.24
Breaking News
|
Drug Delivery
|
Industry News
Bespak Separates Recipharm’s Advanced Delivery Systems BU to Form Standalone CDMO
Spin-out unites 3 sites to create a global CDMO as further significant investments are announced at Holmes Chapel site.
04.02.24
Breaking News
FDA Approves Roche's Itovebi for Breast Cancer
Evonik to Restructure Keto and Pharma Amino Acid Business
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
Cellipont Bioservices, Mongoose Bio Partner to Advance MGB-001
Lipocine Enters Exclusive Supply and Distribution Agreement with Pharmalink
View Breaking News >
CURRENT ISSUE
September 2024
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Post-COVID Trends in Biopharma Contract Manufacturing
Pharma’s Next Frontier: GLP-1s and Other New Therapies
CEO Spotlight: Prasad Raje
HPAPIs Soar Riding the Targeted Drugs Wave
View More >